Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation

scientific article published on December 2005

Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10495-005-1540-9
P698PubMed publication ID16215684
P5875ResearchGate publication ID7549634

P2093author name stringJóźwiak Z
Koceva-Chyła A
Kania K
Skierski J
Jedrzejczak M
P2860cites workActivation of programmed cell death (apoptosis) by adriamycin in human neoplastic cellsQ30716766
P433issue6
P921main subjectdoxorubicinQ18936
cytotoxicityQ246181
P304page(s)1497-1514
P577publication date2005-12-01
P1433published inApoptosisQ15749546
P1476titleMechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation
P478volume10

Reverse relations

cites work (P2860)
Q38822570Anticancer and Antibacterial Activity Studies of Gold(I)-Alkynyl Chromones.
Q91483024Carbon Chain Length Modulates MDA-MB-231 Breast Cancer Cell Killing Mechanisms by Mitochondrially Targeted Aryl-Urea Fatty Acids
Q38734732Cratoxylum formosum (Jack) Dyer ssp. pruniflorum (Kurz) Gogel. (Hóng yá mù) extract induces apoptosis in human hepatocellular carcinoma HepG2 cells through caspase-dependent pathways
Q47250020Cymantrenyl-Nucleobases: Synthesis, Anticancer, Antitrypanosomal and Antimicrobial Activity Studies.
Q37732013Cytotoxic and antimigratory effects of Cratoxy formosum extract against HepG2 liver cancer cells
Q53405069Dissolution and degradation of Fmoc-diphenylalanine self-assembled gels results in necrosis at high concentrations in vitro.
Q34166212Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport
Q33344802Expanding the chemical diversity of CK2 inhibitors.
Q35056083Generic Hockey-Stick Model for Estimating Benchmark Dose and Potency: Performance Relative to BMDS and Application to Anthraquinone
Q34311701Immunogenic cell death and DAMPs in cancer therapy
Q64085621In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers
Q38750151Insights into the in vitro Anticancer Effects of Diruthenium-1.
Q35763090MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction
Q55654248Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A 'Chemobrain' In Vitro Study.
Q51318036Multivalent Aptamer-RNA Conjugates for Simple and Efficient Delivery of Doxorubicin/siRNA into Multidrug-Resistant Cells.
Q92093107Novel Anthraquinone Compounds Induce Cancer Cell Death through Paraptosis
Q43147021Phenotypic drug profiling in droplet microfluidics for better targeting of drug-resistant tumors
Q35824678Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex
Q35559798Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase IIα Catalytic Inhibitors
Q55371625Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.
Q58021059pH-dependent redox mechanism and evaluation of kinetic and thermodynamic parameters of a novel anthraquinone

Search more.